AI Article Synopsis
- The study aimed to see how higher body mass index (BMI) affects outcomes for patients undergoing robotic-assisted pulmonary surgery.
- Over a period of about 4.5 years, researchers examined 280 patients and found no significant differences in major complications between those categorized as normal weight, overweight, and obese, except for higher rates of pneumonia in obese patients.
- The findings suggest that robotic-assisted pulmonary lobectomy is a safe and effective procedure for patients with obesity, despite some increased risks for certain complications like pneumonia.
Article Abstract
Objective: We investigated whether higher body mass index (BMI) affects perioperative and postoperative outcomes after robotic-assisted video-thoracoscopic pulmonary lobectomy.
Methods: We retrospectively studied all patients who underwent robotic-assisted pulmonary lobectomy by one surgeon between September 2010 and January 2015. Patients were grouped according to the World Health Organization's definition of obesity, with "obese" being defined as BMI >30.0 kg/m. Perioperative outcomes, including intraoperative estimated blood loss (EBL) and postoperative complication rates, were compared.
Results: Over 53 months, 287 patients underwent robotic-assisted pulmonary lobectomy, with 7 patients categorized as "underweight," 94 patients categorized as "normal weight," 106 patients categorized as "overweight," and 80 patients categorized as "obese." Because of the relatively low sample size, "underweight" patients were excluded from this study, leaving a total cohort of 280 patients. There was no significant difference in intraoperative complication rates, conversion rates, perioperative outcomes, or postoperative complication rates among the 3 groups, except for lower risk of prolonged air leaks ≥7 days and higher risk of pneumonia in patients with obesity.
Conclusions: Patients with obesity do not have increased risk of intraoperative or postoperative complications, except for pneumonia, compared with "normal weight" and "overweight" patients. Robotic-assisted pulmonary lobectomy is safe and effective for patients with high BMI.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1553350616687435 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Video atlas of pulmonary segmentectomy: robotic-assisted right S3 segmentectomy with 3-dimensional imaging.
Multimed Man Cardiothorac Surg
January 2025
New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom.
Robotic-assisted thoracic surgery has become increasingly utilized in recent years. Complex lung cancer resection surgery can be performed using a robotic approach. It facilitates 3-dimentional visualization of structures, enhanced manipulation of tissues and precise movements.
View Article and Find Full Text PDFThe Scenic Route: Lingular Metastasectomy Through the Right Chest.
Ann Thorac Surg Short Rep
September 2024
Division of Thoracic Surgery, Department of Surgery, Yale-New Haven Hospital, New Haven, Connecticut.
Metastasectomy for isolated pulmonary metastasis can improve disease-free and overall-survival in well-selected patients. When feasible, a minimally invasive wedge resection is the preferred approach. However, a hostile ipsilateral chest can hinder surgical resection.
View Article and Find Full Text PDFInstitutional Experience With Robotic Lobectomy After Neoadjuvant Immunotherapy and Chemotherapy.
Ann Thorac Surg Short Rep
September 2024
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Background: The real-world safety of robotic resections after neoadjuvant chemoimmunotherapy remains poorly defined in patients with non-small cell lung cancer. Due to reported increased operative challenges after neoadjuvant immunotherapy, we aim to describe our early institutional experience and outcomes after robotic resection in this clinical context.
Methods: We performed a retrospective chart review of patients with non-small cell lung cancer who underwent a robotic lobectomy, comparing patients from June 1, 2022, through October 31, 2023, who were treated with neoadjuvant chemoimmunotherapy consistent with the Checkmate-816 protocol and a control group with upfront resection.
Evaluation of the Learning Curve Threshold in Robot-Assisted Lung Cancer Surgery: A Nationwide Population-Based Study.
Cancers (Basel)
December 2024
Service de Biostatistiques et d'Information Médicale (DIM), CHU Dijon Bourgogne, 21000 Dijon, France.
Background: Recent publications suggest that the threshold for validation of the learning curve is 25 procedures. The aim of this study was to evaluate this threshold using another rarely used method, based on a composite quality indicator.
Methods: We included all patients from the French medico-administrative database receiving robot-assisted surgery for lung cancer, with a focus on hospitals performing at least 25 procedures over the period 2019-2022.
Robotic bronchoscopy: Evolution of advanced diagnostic technologies for pulmonary lesions.
Best Pract Res Clin Anaesthesiol
March 2024
1400 Holcombe Blvd, FC 13.2000, Houston, TX, 77030, USA. Electronic address:
Lung cancer is among one of the most commonly diagnosed malignancies and is the leading cause of cancer-related mortality in both men and women globally, with an estimated 1.8 million deaths annually. Moreover, it is also the leading cause of cancer related deaths in the United States (U.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!